SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass. (AP) — Bluebird Bio Inc. (BLUE) on Thursday reported a loss of $60.8 million in its third quarter.
On a per-share basis, the Somerville, Massachusetts-based company said it had a loss of 31 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share.
The biotechnology company posted revenue of $10.6 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $18.3 million.
For the current quarter ending in December, Bluebird said it expects revenue in the range of $25 million.
The company’s shares closed at 38 cents. A year ago, they were trading at $3.02.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLUE at https://www.zacks.com/ap/BLUE
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
